Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Sweeney

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Drug and Chemical Toxicology|January 20, 1998
Risk based tiered approach (RBTASM) for pollution preventionR G Elves, L M Sweeney, C Tomljanovic
Chemico-Biological Interactions|June 9, 2001
Development of a preliminary physiologically based toxicokinetic (PBTK) model for 1,3-butadiene risk assessmentL M Sweeney, M W Himmelstein, M L Gargas
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 7, 2005
Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetateC R Kirman, L M Sweeney, R Corley, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 24, 2010
A cell culture analogue of rodent physiology: Application to naphthalene toxicologyL M Sweeney, M L Shuler, J G Babish, et al.
Regulatory Toxicology and Pharmacology : RTP|November 19, 2003
Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modelingC R Kirman, L M Sweeney, M E Meek, et al.
Toxicology|October 28, 1996
Physiologically based pharmacokinetic modeling of blood and tissue epoxide measurements for butadieneL M Sweeney, M W Himmelstein, P M Schlosser, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|January 27, 2009
Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestionM L Gargas, C R Kirman, L M Sweeney, et al.
Annals of Biomedical Engineering|March 1, 1996
A preliminary physiologically based pharmacokinetic model for naphthalene and naphthalene oxide in mice and ratsL M Sweeney, M L Shuler, D J Quick, et al.
Carcinogenesis|April 1, 1997
Physiologically based pharmacokinetic modeling of 1,3-butadiene, 1,2-epoxy-3-butene, and 1,2:3,4-diepoxybutane toxicokinetics in mice and ratsL M Sweeney, P M Schlosser, M A Medinsky, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|May 28, 2013
Comparison of PBTK model and biomarker based estimates of the internal dosimetry of acrylamideR S DeWoskin, L M Sweeney, J G Teeguarden, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Drug and Chemical Toxicology|January 20, 1998
Risk based tiered approach (RBTASM) for pollution preventionR G Elves, L M Sweeney, C Tomljanovic
Chemico-Biological Interactions|June 9, 2001
Development of a preliminary physiologically based toxicokinetic (PBTK) model for 1,3-butadiene risk assessmentL M Sweeney, M W Himmelstein, M L Gargas
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 7, 2005
Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetateC R Kirman, L M Sweeney, R Corley, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 24, 2010
A cell culture analogue of rodent physiology: Application to naphthalene toxicologyL M Sweeney, M L Shuler, J G Babish, et al.
Regulatory Toxicology and Pharmacology : RTP|November 19, 2003
Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modelingC R Kirman, L M Sweeney, M E Meek, et al.
Toxicology|October 28, 1996
Physiologically based pharmacokinetic modeling of blood and tissue epoxide measurements for butadieneL M Sweeney, M W Himmelstein, P M Schlosser, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|January 27, 2009
Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestionM L Gargas, C R Kirman, L M Sweeney, et al.
Annals of Biomedical Engineering|March 1, 1996
A preliminary physiologically based pharmacokinetic model for naphthalene and naphthalene oxide in mice and ratsL M Sweeney, M L Shuler, D J Quick, et al.
Carcinogenesis|April 1, 1997
Physiologically based pharmacokinetic modeling of 1,3-butadiene, 1,2-epoxy-3-butene, and 1,2:3,4-diepoxybutane toxicokinetics in mice and ratsL M Sweeney, P M Schlosser, M A Medinsky, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|May 28, 2013
Comparison of PBTK model and biomarker based estimates of the internal dosimetry of acrylamideR S DeWoskin, L M Sweeney, J G Teeguarden, et al.
Pageof 2